scholarly journals Recommendations for outpatient respiratory rehabilitation of long COVID patients

2021 ◽  
Author(s):  
M. García-Saugar ◽  
C. Jaén-Jover ◽  
S. Hernández-Sánchez ◽  
E.J. Poveda-Pagán ◽  
C. Lozano-Quijada
Keyword(s):  
Respiratory Rehabilitation

Respiratory rehabilitation with heat moisture exchanger after total laryngectomy: long-term evaluation

2019 ◽  
Vol 69 (2) ◽  
Author(s):  
Eugenia Allegra ◽  
Ignazio La Mantia ◽  
Maria R. Bianco ◽  
Nicolò Marino ◽  
Alessio Fallica ◽  
...  
Keyword(s):  
Total Laryngectomy ◽  
Moisture Exchanger ◽  
Term Evaluation ◽  
Respiratory Rehabilitation

Non-Contact Measurement of Respiratory Function for Judging the Effect of Respiratory Rehabilitation in Patients With SMID

2020 ◽  
Author(s):  
Remi Kosumi ◽  
Ryota Sakamoto ◽  
Norihiko Kato ◽  
Ken’ichi Yano ◽  
Shotaro Iwamoto ◽  
...  
Keyword(s):  
Respiratory Function ◽  
Direct Contact ◽  
Three Dimensional ◽  
Mental Disabilities ◽  
Gas Analyzer ◽  
Contact Measurement ◽  
Respiratory Parameters ◽  
Severe Motor ◽  
Expired Gas ◽  
Respiratory Rehabilitation

Abstract Patients with SMID (severe motor and intellectual disabilities) have severe limb disorders and severe mental disabilities. More than half of their deaths are due to respiratory disorders. Therefore, respiratory rehabilitation is important. The effect of respiratory rehabilitation is generally determined by measuring respiratory volume and rate with an expired gas analyzer. However, the equipment is expensive and requires direct contact, making it difficult to use. The purpose of this research is to develop a non-contact measurement system for respiratory function to assess the effect of respiratory rehabilitation in patients with SMID. The proposed method detects respiration by depth change of the abdomen measured using a three-dimensional camera designed to identify body tremor /motion and respiration based on respiratory parameters and individually adapted parameters. Finally, we verify the rehabilitation effect of an RTX respirator on patients with SMID and the effectiveness of the proposed method in an experiment.

Paperometer: A Low-Cost Incentive Spirometer

2020 ◽  
Author(s):  
Shonit Nair Sharma ◽  
Devrina Chidambaram ◽  
Gianna Mizzi ◽  
Daniel Rosen ◽  
Kristin Slaughter ◽  
...  
Keyword(s):  
Lung Function ◽  
Medical Devices ◽  
Low Cost ◽  
Environmental Friendliness ◽  
Global Pandemic ◽  
Innovative Solution ◽  
Repeated Use ◽  
Functional Prototype ◽  
The Cost ◽  
Respiratory Rehabilitation

Abstract As a preemptive response to the widespread need for respiratory medical devices developing in the wake of the COVID-19 pandemic, we propose a low-cost incentive spirometer for respiratory rehabilitation in patients with reduced lung function. An incentive spirometer manufactured entirely out of recyclable material, termed “Paperometer,” aims to address the multifaced problem of medical device inaccessibility: high cost, lack of user- or environmental-friendliness, and unavailability to those who need them the most. Operating in accordance with governing physical formulae including Ohm’s law and the Hagen-Poiseuille equation, Paperometer is intended to improve the user’s lung function through repeated use of the device, which facilitates slow, deep breaths of air. Several prototypes were created based on a list of design criteria established through background research and stakeholder interviews. From four initial prototypes, all created predominantly from simple foldable geometries, one design was selected for further iteration. The most promising functional prototype was crafted from recyclable plastic and paper folded into various shapes including a box, tube, and pinwheel. The Paperometer concept stands as an innovative solution to reduce the cost and environmental burden of meeting the demand for medical devices. Once validated, the device may serve as an important tool in combating the ongoing global pandemic.

scholarly journals Therapeutic guidelines for the treatment of cystic fibrosis

Pharmacia ◽  
2021 ◽  
Vol 68 (1) ◽  
pp. 151-154
Author(s):  
Maria Becheva ◽  
Petar Atanasov
Keyword(s):  
Cystic Fibrosis ◽  
Autosomal Recessive ◽  
Autosomal Recessive Disease ◽  
Clinical Evaluations ◽  
Number Of Patients ◽  
Therapeutic Guidelines ◽  
Therapeutic Measures ◽  
One Year ◽  
Respiratory Rehabilitation

Cystic fibrosis (CF) is a complex, systemic autosomal recessive disease that affects the functions of the respiratory system, the digestive tract and all exocrine glands. The frequency for Europe averages 1: 2500 to 1: 3500 live births. The total number of patients with cystic fibrosis in Bulgaria is about 180. About 10% of the patients are diagnosed at birth. About 60–70% of patients are diagnosed before they reach one year of age. Respiratory symptoms predominate in the clinical picture in patients with cystic fibrosis and determine the prognosis in more than 90% of the patients. The treatment of patients with cystic fibrosis is strictly individualized, pharmacological and non-pharmacological and requires a comprehensive therapeutic approach. The complex therapy also includes bronchodilators, NSAIDs, corticosteroids, respiratory rehabilitation in combination with general body massage. Continued courses of broad-spectrum antibiotics are required to suppress chronic infection. With the progression of the disease, complications such as atelectasis, pneumothorax and pulmonary hemorrhages are observed. The establishment of specialized centers with trained and experienced professionals is essential in order to provide optimal patient care. These include frequent clinical evaluations, follow-up of complications, and early interventions for the treatment of patients with cystic fibrosis. The aim of the article is to familiarize the audience with the therapeutic measures applied in the treatment of patients with cystic fibrosis.

Sign in / Sign up

Export Citation Format

Share Document